The Lancet Neurology · 2012 · 284 citations · 28 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyAnticoagulant TherapyAnticoagulation TherapyAtrial FibrillationStrokeThrombosisThrombosis PreventionAtrial Fibrillation-related ThromboembolismPost-stroke AnticoagulationSafety Subgroup AnalysisTransient Ischemic Attack Prevention
28
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text